We want to break HIV and end AIDS
Help us test a new solution
Read about this science 35 years in the making, and how our unique structure makes the most out of your charitable donation. Advancing research today, providing access to those who need it in the future.
Questions & Answers
What will my donation fund?
We are currently working to optimize the HIV E-Vaccine with the assistance of AI. We hope to produce a next-generation E-gp120 formulation with optimized spatial positioning of the crucial noncovalently-binding amino acids and the covalently-binding E group in partnership with an AI-powered molecular dynamics company.
Why is there so much skepticism around developing an effective HIV vaccine?
After 30 years of promises and billions of dollars spent, pessimism exists over the prospects of developing an effective HIV vaccine. Our data argues otherwise, and we are optimistic about the E-vaccine’s potential. Please refer to our Science Page to hear more about what our advisors think.
How will #endHIV win over the remaining scientists who are skeptical about the clinical promise of this vaccine?
As we advance our clinical program, #endHIV will directly support several collaborations with top HIV researchers. Our goal is to provide data-driven conclusions proving that the vaccine induces sufficient synthesis of protective antibodies that prohibit development of HIV resistance and control latent HIV reservoirs.
What has been done already?
This vaccine has been developed over the past 25 years with over $15 million in dedicated funding from the National Institutes of Health. The #endHIV team has facilitated initial review from the FDA which we found favorable and provided us clear next steps to move to human trials. Now we are optimizing the formulation of the HIV E-vaccine with AI before moving to human trials.
Make HIV History. Giving even a small amount has a tremendous impact.
Current Situation: Massive cuts to the NIH, USAID, and LBGTQ+ health support have suspended HIV research, prevention, and care. In particular, HIV prevention and treatment in Africa is in crisis following cuts to USAID.
We don’t just want to treat HIV, we want to cure HIV.
Today’s conventional view is that lifelong, daily treatment for HIV+ people is the last frontier in the global war on HIV/AIDS. We think more should be done to address this challenge, and our disruptive vaccine is intended to provide a functional cure. #endHIV challenges how academia, pharmaceutical companies, and charities work together to test innovative cure approaches.
Give Now Share
We are working on a promising solution to the HIV/AIDS pandemic, and now want to turn that potential cure into a reality. Read about this science 35 years in the making, and how our unique structure makes the most out of your charitable donation.
Advancing research today, providing access to those who need it in the future.
Stay Connected
Join our mailing list to stay informed.
Give Now Share
Help Us Make HIV History Giving even a small amount
has a tremendous impact. Give Now.
